Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo’s ViiV Joins J&J’s Janssen to Develop Single-Pill HIV Drug
Glaxo’s ViiV Joins J&J’s Janssen to Develop Single-Pill HIV Drug
Glaxo’s ViiV Joins J&J’s Janssen to Develop Single-Pill HIV Drug
Submitted by
admin
on June 12, 2014 - 9:26am
Source:
Bloomberg
News Tags:
GSK
ViiV
JNJ
Janssen
HIV
Headline:
Glaxo’s ViiV Joins J&J’s Janssen to Develop Single-Pill HIV Drug
Do Not Allow Advertisers to Use My Personal information
